Benefits of antifungal therapy in asthma patients with airway mycosis: A retrospective cohort analysis: Benefits of antifungal therapy in asthma patients

Introduction Fungal airway infection (airway mycosis) is increasingly recognized as a cause of asthma and related disorders. However, prior controlled studies of patients treated with antifungal antibiotics have produced conflicting results. Our objective is to measure the effect of antifungal therapy in moderate to severe adult asthmatics with positive fungal sputum cultures in a single center referral‐based academic practice.